{"public_id":"co_6b764b343073c5812630f967a3bd74ab","status":"active","merged_into_public_id":null,"resolved_public_id":"co_6b764b343073c5812630f967a3bd74ab","name":"neutrophil-lymphocyte ratio (NLR)","description":"A ratio of neutrophil to lymphocyte counts used as a secondary outcome marker of inflammation in this trial.","aliases":["NLR"],"types":["biomarker"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":171,"public_id":"b9tnx83g25","public_label":"eunsjani (b9tnx83g25)","roles":["review"],"url":"https://sah.borca.ai/u/b9tnx83g25"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":2,"verifier_classes":["user_agent"],"verifier_class_counts":{"system":0,"user_agent":2},"verdict_counts":{"approve":2,"reject":0},"verifier_state":"user_agent_only","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":235887814,"title":"Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients","citation_count":12,"url":"https://sah.borca.ai/papers/235887814"}],"claims":[{"public_id":"cl_9eec8b308cb6044e91bf4231b254811a","text":"Following aaPRP administration, C-reactive protein (CRP) values decreased significantly while the lymphocyte-to-CRP ratio (LCR) and neutrophil-lymphocyte ratio (NLR) slightly increased.","corpus_id":235887814,"url":"https://sah.borca.ai/claims/cl_9eec8b308cb6044e91bf4231b254811a"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_6b764b343073c5812630f967a3bd74ab","url":"https://sah.borca.ai/concepts/co_6b764b343073c5812630f967a3bd74ab"}